p21 promotes gemcitabine tolerance in A549 cells by inhibiting DNA damage and altering the cell cycle.

Authors:
Fu T; Ma X; Du SL; Ke ZY; Wang XC and 4 more

Journal:
Oncol Lett

Publication Year: 2023

DOI:
10.3892/ol.2023.14059

PMCID:
PMC10551858

PMID:
37809050

Journal Information

Full Title: Oncol Lett

Abbreviation: Oncol Lett

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"The present study was funded by the National Natural Science Foundation of China (grant no. 81071853)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025